MAbs

Moreover the epitopes recognised by the Monoclonal antibodies (MAbs) specific for HRP that are available for and used in RDTs also vary significantly between parasites

PLoS ONE Alerts: New Articles Dionicia Gamboa et al. 2010

While available evidence indicates that HRP2 is the major target detected in HRP2 RDTs, HRP3 is also secreted and can be detected by MAbs raised against HRP2

PLoS ONE Alerts: New Articles Dionicia Gamboa et al. 2010

The study aims to evaluate MabCure's panel of anti-ovarian MAbs in diagnosing ovarian cancer in the blood and urine of patients suspected of having the disease.

THE MEDICAL NEWS Editors 2010

MAbs for early detection of cancerTwo sets of recommendations issued earlier this month have revised longstanding guidelines concernin ...

THE MEDICAL NEWS Antoine Maurice Devine 2010

(OTCBB: MBCI) ( "MabCure"), a biotechnology company using its proprietary technology to create highly specific monoclonal antibodies (MAbs) for the early detection of cancer, today announced that it has recently completed a private placement in the aggregate amount of $1 million.

THE MEDICAL NEWS Editors 2010

In the area of research and development pertaining to recombinant products, the company is developing Novel Drug Delivery System for proteins, a cloning facility, introducing novel production platforms, developing MAbs and recombinant products (cytokines, hormones and blood factors).

News Centre@myiris.com India's Most Comprehensive Financial Destination 2009

The facility, dedicated for Monoclonal Antibodies (MAbs), will undertake large-scale manufacturing of the recombinant product with a capacity of 5,000 litres in phases.

News Centre@myiris.com India's Most Comprehensive Financial Destination 2009

Intas Biopharmaceuticals (IBPL), India ` s leading biotechnology company, signed a Memorandum of Understanding (MoU) with Government of Gujarat for setting up a separate manufacturing facility for Monoclonal Antibodies (MAbs), a recombinant mammalian platform product.

News Centre@myiris.com India's Most Comprehensive Financial Destination 2009

MAbs function as production repositories for developing drugs and are used in the manufacture of highly ...

Random feeds from Syndic8.com 2009

The setting up of MAbs facility in Gujarat is one-of-its-kind of initiative for the state that has always welcomed and promoted new technology initiatives from Intas Biopharmaceuticals.

News Centre@myiris.com India's Most Comprehensive Financial Destination 2009